Topiramate treatment of pediatric metabolic dysfunction–associated steatotic liver disease: A descriptive cohort study
Kohut T, Tou A, Carr E, Xanthakos S, Arce‐Clachar A, Fawaz R, Valentino P, Panganiban J, Mouzaki M. Topiramate treatment of pediatric metabolic dysfunction–associated steatotic liver disease: A descriptive cohort study. Journal Of Parenteral And Enteral Nutrition 2024, 49: 308-313. PMID: 39720872, DOI: 10.1002/jpen.2722.Peer-Reviewed Original ResearchBody mass indexBody mass index z-scoreBaseline to 3Alanine aminotransferaseGlycated hemoglobinLifestyle modificationZ-scoreAlanine aminotransferase normalizationPatients aged <Weight loss medicationsAlanine aminotransferase levelsMild side effectsSerum alanine aminotransferaseObesity pharmacotherapyTopiramate treatmentPrimary treatmentLaboratory valuesOff-labelPediatric obesityMass indexTopiramateCohort studySingle agentPrimary outcomeLipid profile
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply